ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993

Center For Health Policy And Outcomes Established At Memorial Sloan Kettering. ONS Marks 35th Year.

July 9, 2010

NCAB Approves Fallout Study On Split Vote

March 13, 1981